Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer

BACKGROUND: There is a clinical need for routinely available genomic biomarker testing in newly diagnosed ovarian cancer. In the current study we performed molecular cytogenetics using a validated array based comparative genomic hybridization (array CGH) assay to screen for the presence of predictiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunn, Shelly, Reveles, Xavier, Weldon, Korrie, Barrera, Andres, Ishaque, Mariam, Taylor, Dale, McCaskill, Chris, Kim, Jaeweon, Shah, Rashmi, Mohammed, Mansoor, Barry, Todd, Kaiser, Brianne, Patnaik, Amita, Tolcher, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601995/
https://www.ncbi.nlm.nih.gov/pubmed/23289505
http://dx.doi.org/10.1186/1757-2215-6-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601995/
https://www.ncbi.nlm.nih.gov/pubmed/23289505
http://dx.doi.org/10.1186/1757-2215-6-2

Ejemplares similares